Responder and biomarker mapping
Which tumor models respond, and which molecular features explain it? Get responder groups and candidate biomarkers for stratification.
Use Cases
Start with the decision your program needs to make.
We work with biotech and pharmaceutical teams on focused questions about oncology treatment response, from a first pilot to longer co-development.
Where we help
Combination and resistance profiling
Which combinations with standard-of-care therapies have a mechanistic rationale, and where does resistance emerge?
Compound and formulation prioritization
Which candidates deserve the next round of investment? Compare them on response and mechanism in one defined panel.
Tumor safety and interaction profiling
Do cannabinoids or ECS-targeting compounds affect tumor growth or the activity of cancer therapies? Profile this before it becomes a clinical question.
Indication and subtype scouting
Where does the biology point to the strongest fit for your asset?
Go/no-go support
What evidence would support your next development decision?
Ways to work together
Focused pilot
One defined question, an agreed panel of tumor models and a clear readout.
Co-development
A longer collaboration that combines your assets and questions with our platform.
Scope, deliverables and timing are agreed for each project. We work under NDA and agree data ownership and IP terms upfront.
What you receive
- A structured functional and signaling dataset
- An interpretation report with mechanistic insights
- Biomarker and combination hypotheses
- A recommendation for next experiments or a go/no-go decision
How it works
1 · Discuss
The question and the development context
Tell us about the asset, the observed response pattern and the decision you need to make.
2 · Assess
Scientific fit and available evidence
We discuss the biological context, available data or models, and the feasibility of a focused collaboration.
3 · Define
A shared research plan
Where there is a fit, we define the scope, milestones and expected outputs together.
4 · Deliver
Run the study and review the findings
We run the study in our lab, share results at agreed points and review the findings with you.
Tell us what you need to understand.
A short, non-confidential description of your compound and the decision ahead is enough to start.
Discuss a project